NCSA 30 | 1992 January
archive,date,ajax_updown_fade,page_not_loaded,,tactile-ver-1.8.1, vertical_menu_background_opacity,smooth_scroll,wpb-js-composer js-comp-ver-,vc_responsive

January 1992

Eli Lilly develops asthma drug

David Herron of Eli Lilly and Company harnessed high-performance computing to aid the fight against asthma from the moment the company joined NCSA's Industrial Program, now the Private Sector Program, in 1987. Herron and the Lilly research team studied a class of small molecules known as leukotrienes, which cause the lungs to stiffen and become irritated. Lilly's goal was to develop receptor antagonists that recognize...

Read More
Cookie Settings